KYTHERA BIOPHARMACEUTICALS INC
DelistedCIK 1436304fmd_1FAGEZK2QYNDNP1W29A8150GJ4Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Jun 30, 2015, 19 periods
Latest annual · FY2012
Millions- Gross profit
- 18
- Operating income
- (132)
- Net income
- (136)
- Free cash flow
- (62)
Latest quarter · Q2 FY2015
Millions- Operating income
- (36)
- Net income
- (37)
- Free cash flow
- (26)
KYTHERA BIOPHARMACEUTICALS INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2014 | FY2013 | Change | Source |
|---|---|---|---|---|
| Operating income | -$131.7 million | -$50.1 million | 10-K 2015-03-02 · proof | |
| Net income | -$135.6 million | -$51.9 million | 10-K 2015-03-02 · proof | |
| Cash from operating activities | -$59.5 million | -$44.9 million | 10-K 2015-03-02 · proof | |
| Free cash flow | -$61.6 million | -$44.9 million | 10-K 2015-03-02 · proof | |
| Total assets | $103.4 million | $173.4 million | -40.4% | 10-K 2015-03-02 · proof |
| Total liabilities | $44 million | $23.6 million | +86.6% | 10-K 2015-03-02 · proof |
| Cash and cash equivalents | $29.2 million | $111.5 million | -73.8% | 10-K 2015-03-02 · proof |
- What was KYTHERA BIOPHARMACEUTICALS INC's operating income in fiscal 2014?
- KYTHERA BIOPHARMACEUTICALS INC reported operating income of -$131.7 million for fiscal 2014 (the year ended Dec 31, 2014), against -$50.1 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2015. SEC
- What was KYTHERA BIOPHARMACEUTICALS INC's net income in fiscal 2014?
- KYTHERA BIOPHARMACEUTICALS INC reported net income of -$135.6 million for fiscal 2014 (the year ended Dec 31, 2014), against -$51.9 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2015. SEC
- What was KYTHERA BIOPHARMACEUTICALS INC's cash from operating activities in fiscal 2014?
- KYTHERA BIOPHARMACEUTICALS INC reported cash from operating activities of -$59.5 million for fiscal 2014 (the year ended Dec 31, 2014), against -$44.9 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2015. SEC
- What was KYTHERA BIOPHARMACEUTICALS INC's free cash flow in fiscal 2014?
- KYTHERA BIOPHARMACEUTICALS INC reported free cash flow of -$61.6 million for fiscal 2014 (the year ended Dec 31, 2014), against -$44.9 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2015. SEC
- What are KYTHERA BIOPHARMACEUTICALS INC's total assets?
- As of Dec 31, 2014, KYTHERA BIOPHARMACEUTICALS INC reported total assets of $103.4 million, against $173.4 million a year earlier (-40.4%). Source: the 10-K filed with the SEC on Mar 2, 2015. SEC
- What are KYTHERA BIOPHARMACEUTICALS INC's total liabilities?
- As of Dec 31, 2014, KYTHERA BIOPHARMACEUTICALS INC reported total liabilities of $44 million, against $23.6 million a year earlier (+86.6%). Source: the 10-K filed with the SEC on Mar 2, 2015. SEC
- What are KYTHERA BIOPHARMACEUTICALS INC's cash and cash equivalents?
- As of Dec 31, 2014, KYTHERA BIOPHARMACEUTICALS INC reported cash and cash equivalents of $29.2 million, against $111.5 million a year earlier (-73.8%). Source: the 10-K filed with the SEC on Mar 2, 2015. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1436304&period_type=annual&limit=5"Information only, not investment advice.